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Abstracts / Urological Science 27 (2016) S1eS23S22Purpose: Some studies reported a comparable oncological outcome and
better early continence rate of Retzius-preserving robotic assisted lapa-
roscopic radical prostatectomy (RALP). We want to compare the early
perioperative and continence outcome. And we are also eager to know if
the learning curve of Retzius-preserving surgery would compromise the
outcome or not?
Materials and Methods: We selected patient with organ-conﬁned
prostate cancer ( cT2c), PSA  40, Gleason score of biopsy  8, prostate
volume  50 ml and BMI < 35. We design a case control matching study
with 20 cases of each Retzius-preserving RALP and conventional RALP
group. Postoperative parameter and early continence result was
compared.
Results: From Febuary, 2015 to Febuary, 2016, total 84 cases of RALP were
performed in VGHTC. Twenty of them underwent Retzius-preserving
RALP. There is no statistical difference of preoperative characteristics.
There were no signiﬁcant differences in estimated blood loss, mean length
of hospital stay, intra- and postoperative complication rates, pathological
stage of disease, Gleason scores, tumour volumes and positive surgical
margins between the conventional RALP and Retzius-sparing RALP groups.
However, console time, Vesicourethral anastomosis time were longer for
Retzius-sparing RALP. There is no signiﬁcant difference of early continence
at 4 weeks between two groups.
Conclusion: Based on the early result of this study, Retzius-preserving
RALP is a feasible and safe treatment choice for localized prostate cancer.
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Purpose: Prostate cancer is a common cancer and it can often be treated
successfully. The 15-year survival rate is more than 90% in patients with
early stage, However, once the tumor metastasis occurred, the prognosis
got signiﬁcantly worse. Therefore, to identify patients with malignant
potential while diagnosing might improve clinical outcome. The aim of
this study was to evaluate the expression of SPOCK1 (sparc/osteonectin,
cwcv and kazal-like domains proteoglycan (testican) 1) and its clinical
signiﬁcance in prostate cancer.
Materials and Methods: SPOCK1 expression was measured by immuno-
histochemical staining of samples from 71 patients with prostate cancer.
The correlation between SPOCK1 expression and clinicopathological fea-
tures was quantitatively analyzed. The prognostic value of SPOCK1 for
overall survival was determined by Kaplan-Meier analysis and Cox pro-
portional hazard models. For underlying molecular mechanism, prostate
cancer cell lines were used and SPOCK1 expression was knock-down via
siRNA. Migration and invasion assay were performed to determined the
tumor malignancy. The downstream signaling pathway will be analyzed
with real-time RT-PCR and western blot.
Results: Seventy-one patients with mean age of 74.4 years (range 59 to 97
years) were included. Clinicopathological features, including histological
type, differentiation, lymph node metastasis, TNM stage, and tumor size
were assessed. Patients with high SPOCK1 expression were more prone to
be advanced stage. As to the prognosis, the median follow-up for overall
survival was 5.2± 2.9 years (range: 0.7 to 11.8 years). Moreover, a high
POCK1 expression level was correlated with poor survival. The underlying
mechanism is under investigation.
Conclusion: Our results suggest that SPOCK1 expression is enhanced in
prostate cancer. High SPOCK1 expression, either alone or in combinationwith other pathologic staging factors, may therefore serve as a poor
prognostic marker for prostate cancer.
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Purpose: Physicians ordering contrast imaging should identify patient
risks and prevent contrast-induced nephropathy (CIN). Our aim is to
determine whether patient-speciﬁc or non-patient-speciﬁc alerts in clin-
ical decision support system triggers higher compliance with guidelines to
prevent CIN.
Materials and Methods: A 3-arm cluster randomized controlled trial was
conducted in two university hospitals using the same computerized
physician order entry. Eligible physicians were randomized to receive
patient-speciﬁc alerts, non-patient-speciﬁc alerts or no intervention
(groups 1e3 respectively). Patient-speciﬁc alerts automatically prompted
only when CIN risk was encountered and provides patient-speciﬁc data to
physicians, while non-patient-speciﬁc alerts always prompted regardless
of risk without providing patient-speciﬁc data. CIN risk was stratiﬁed as
high-risk, low-risk and minimal-risk according to patient's renal function.
Contrast imaging order-cancellation rate was measured as primary
outcome.
Results: Orders for 5372 patients from 99 physicians were analyzed. Renal
function and risk distributions of patients were not statistically different
among groups. Order-cancellation rates were 32.1%, 14.3%, 1.7% for high
risk patients, and 7.2%, 3.0%, 1.3% for low risk patients in groups 1e3,
respectively. Using generalized linear model, signiﬁcant order-cancellation
factors in at-risk patients were non-patient-speciﬁc alert (p¼ 0.04), pa-
tient-speciﬁc alert (p< 0.0001), high CIN risk (p¼ 0.003), and physicians
with low contrast imaging ordering volume (p< 0.0001). Order-cancella-
tion effects were compared and measured by odds ratio (OR). For high risk
patients, patient-speciﬁc versus non-patient-speciﬁc alerts OR was sig-
niﬁcant at 2.73 (95%CI 1.09e6.84), while patient-speciﬁc vs. control
OR¼ 28.32 (95%CI 3.21e249.65), and non-patient-speciﬁc vs. control
OR¼ 9.17 (95%CI 0.96e87.55).
Conclusion: Patient-speciﬁc alert signiﬁcantly outperformed non-patient-
speciﬁc alert in physician compliance with guidelines.
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Purpose: To analyze the clinical outcome of patients with KC managed
with augmentation enterocystoplasty (AE).
Materials and Methods: We retrospectively collected and analyzed the
medical records and video-urodynamic (VUD) test results of 26 patients
who underwent AE as treatment for refractory KC during the period
2009e2014. Data from VUD studies performed before AE and 3e6 months
after surgery that were analyzed in this study included cystometric
bladder capacity (CBC), post-void residual (PVR) urine volume, maximum
urinary ﬂow rate (Qmax), voided volume and bladder compliance. A self-
report questionnaire was used to assess patient satisfaction with AE.
Results: Patients included 14women and 12men aged 20e43 years (mean
age, 28.5 years) with an average duration of ketamine abuse of 4.7 years
(range, 1e7 years). All patients had contracted bladder, 9 had hydro-
nephrosis and 10 had vesicoureteral reﬂux (VUR). There was signiﬁcant
improvement in CBC (52.7± 29.7 v 327± 69.4 mL, P< 0.0001), Qmax
(6.94± 4.32 v 13.7± 4.96 mL/s, P< 0.0001), PVR (8.08± 19.2 v
82.6± 91.5 mL, P< 0.0001), voided volume (44.1± 28.3 v 250.7 ± 133.4 mL,
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AE. Hydronephrosis resolved in 7 patients after AE and VUR resolved in all
patients who underwent AE with ureteral reimplantation. Perioperative
complications included postoperative intestinal obstruction in one patient,
short-term urine leakage in one patient and dysuria due to narrowing
requiring transurethral incision of the enterovesical anastomosis in two
patients. There were no cases of urosepsis and no deaths in this series. All
patients who stopped using ketamine were free of bladder pain post-
operatively. However, 10 patients who reused ketamine had recurrent
bladder pain and recurrent urinary tract infection.
Conclusion: AE is effective at treating KC-induced bladder pain and
restoring normal lower urinary tract function. However, absolute cessation
of ketamine is the key to success in KC treatment.
Renal transplantation
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PERIPHERAL BLOOD-DERIVED ENDOTHELIAL PROGENITOR CELL
THERAPY PREVENTED DETERIORATION OF CHRONIC KIDNEY DISEASE
IN RATS
Yen-Ting Wu M.D.1, Yen-Ta Chen M.D.1, Hon-Kan Yip 2, Tien-Hung
Huang 3, Kay L.H. Wu Ph.D. 3, Julie Y.H. Chan Ph.D. 3. 1Kaohsiung Chang
Gung Memorial Hospital and Chang Gung University College of Medicine,
Division of Urology, Taiwan; 2Department of Cardiology, Institute for
Translational Research in Biomedicine, Taiwan; 3 Institute for Translational
Research in Biomedicine, Taiwan
Purpose: This study tested the hypothesis that peripheral blood-derived
endothelial progenitor cell (PBDEPC) therapy can impede the deterioration
of chronic kidney disease (CKD) induced by 5/6 nephrectomy in rats.
Materials and Methods: Adult-male rats (n¼ 30) were equally catego-
rized into group 1 (sham control), group 2 (CKD only) and group 3 [CKD +
PBDEPC (left intra-arterial (3.3105) and penile vein (6.7105) in-
jections by day 14 after CKD induction].
Results: By day 60, kidney blood ﬂow (KBF) was signiﬁcantly lower in
group 2 than that in groups 1 and 3, and signiﬁcantly lower in group 3 than
that in group 1, whereas the levels of serum creatinine, and kidney injury
score and size showed an opposite pattern compared to that of KBF among
all groups (all p< 0.001). Protein expressions of apoptotic (caspase 3,
PARP), inﬂammatory (TNF-a, MMP-9), oxidative-stress (oxidized protein,
NOX-1), ﬁbrotic (Smad3, TGF-b), and hypoxic/ischemic cell-stress (HIF-1a,
p-Akt) biomarkers showed an opposite pattern, whereas angiogenesis at
protein (eNOS, CD31) and cellular (CD31+, CXCR4+) levels showed an
identical pattern compared to that of blood ﬂow in all groups (all p< 0.01).
Other pro-angiogenic biomarkers (SDF-1a, CXCR4, VEGF) at protein and
cellular levels and antioxidants (HO-1+, NQO 1, GR+) at cellular level
showed progressive signiﬁcant increase from groups 1 to 3 (all p< 0.001).
Conclusion: The results support that PBDEPC therapy effectively inhibits
the propagation of CKD and the deterioration of renal function through
enhancement of angiogenesis, blood ﬂow, and anti-oxidative capacity as
well as suppression of inﬂammation, oxidative stress, apoptosis, and
ﬁbrosis in a rodent model.
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Purpose: This is the ﬁrst report on the relationship between duration of
ketamine abuse and lower urinary tract symptoms and lowmood in young
adults.Materials and Methods: After obtaining IRB approval, a structured ques-
tionnaire was distributed to young adults who were caught by policemen
for using ketamine and were asked to attend educational course in Nov.,
2015 and Feb., 2016.
The questionnaire consists of duration and dose of ketamine abuse, In-
ternational Prostate Symptoms Score (IPSS), short form International
Inventory for Erectile Function (IIEF-5), female sexual function index
(FSFI) and brief score of mood (BSRS-5). Mild, moderate and severe
depression is suspected if BSRS-5 sum score are 6e9, 10e15 and 15e20,
respectively.
Results:Of 130 persons 14 (11.8%) refused to ﬁll questionnaire. Mean age of
the 116 persons was 27.1± 4.4 years. Education level of high school or
under was 81%. Mean duration of ketamine abuse in 84 persons was 24.5
months. Duration of abuse was <12months in 32 (38.1%),12e24months in
27 (32.1%) and >24 months in 25 (29.8%). Duration of ketamine abuse was
positively related to IPSS score (p¼ 0.05) and BSRS score (p¼ 0.037).
Erectile dysfunction was noted in 19 (28.2%) of 60 male abusers. Dose of
ketamine abuse was note associated with IPSS or BSRS.
Conclusion: Most ketamine abusers were male with low educational
levels. Duration of ketamine abuse was associated with lower urinary tract
symptoms and low mood. In addition, erectile dysfunction was frequently
observed in ketamine abusers.
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Purpose: Information asymmetry and universalism of medical profession
in physician-patient relationship (PPR) have long been used to explain
problem of doctor-patient communication. The picture of short period of
visit and too many professional terms applied are always shown in out-
patient service. In fact, from the perspective of multiculturism, doctor and
patient communicates with each other involving “subject with multiple
identities”. In this study, difference of perception of PPR between doctor
and patient is taken into consideration to investigate the PPR from
perspective of “medicine of sociology”.
Materials and Methods: The measurement of quality of medical service
for PPR in this study is derived from the gap model of PZB. Five domains of
which consists in questionnaire are subjectivity, power/knowledge, ethic
of responsibility, ethic of care and literacy of multiculturism, respectively.
The data were collected by face to face interview in one regional teaching
hospital in Kaohsiung city. 150 patients of out-patient department and 15
doctors whose various specialist is physician, surgeon, gynecologist and
pediatrician enrolled in this study. From perspective of multiculturism,
statistic analysis by SPSS is performed to investigate the effect of difference
of perception in PPR.
Results: Domains of ethic of responsibility and care, subjectivity, and skills
of literacy of multiculturism have signiﬁcant inﬂuence on difference of
perception in PPR.
Conclusion: Effectiveness in shortening the difference of perception in
PPR to achieve improved PPR is to be determined. In addition to hardware
facilities and medical profession, inter-subjectivity between patient and
doctor interaction, care and literacy with humanity remained important
components to construction satisﬁed PPR. Further, by development in
praxis and focus on trend of multiculturism, imbalanced PPR may ﬁnd the
way out.
